Chronic Myeloid Leukemia‎

British Society for Haematology Guideline Update for the Diagnosis and Management of Chronic Myeloid Leukemia

By

Caleb Rans

Publish Date October 23, 2020

The British Society for Haematology has published updated guidelines for the diagnosis and management of chronic myeloid leukemia in adults and children.

First-line Therapy Response vs Switching Treatments in Chronic Myeloid Leukemia

By

Patricia Chaney

Publish Date October 20, 2020

CP-CML patients who remain on first-line TKI therapy have better clinical responses than patients who switch within the first 3 years.

Patients With CML Continue to Be Prescribed Costly Second-Gen TKIs

By

Christina Bennett, MS

Publish Date October 13, 2020

Most patients with CML are being prescribed costly second-generation TKIs, even though generic imatinib has been available since 2016.

Early Monitoring of Chronic Myeloid Leukemia Might Dictate TKI Switch

By

Leah Lawrence

Publish Date April 24, 2020

Lack of initial response to imatinib might indicate need to switch to dasatinib.

Radotinib May Have Similar Efficacy to Imatinib in Chronic Myeloid Leukemia

By

Jonathan Goodman, MPhil

Publish Date March 2, 2020

Researchers reported long-term follow-up results from the phase 3 RERISE study, which assessed the efficacy of radotinib compared with imatinib for CML treatment.

Leukemia Clinical Trials

Clinical Trial: Molecular Epidemiology of Childhood Leukemia (Aka The California Childhood Leukemia Study) (CCLS)

Clinical trial focusing on the molecular epidemiology of childhood leukemia. Molecular Epidemiology of Childhood Leukemia (Aka The California Childhood Leukemia Study) (CCLS)

Clinical Trial: Genetic Study of Chronic Lymphocytic Leukemia Families

Clinical trial focusing on genetics and chronic lymphocytic leukemia. Genetic Study of Chronic Lymphocytic Leukemia Families

Clinical Trial: Banking of Chronic Lymphocytic Leukemia Tumor Cells for Vaccine Generation

Clinical trial focusing on vaccine generation from chronic lymphocytic leukemia tumor cells. Banking of Chronic Lymphocytic Leukemia Tumor Cells for Vaccine Generation

Clinical Trial: Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia

Clinical trial focusing on GNKG168. Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia

Clinical Trial: Study of Carfilzomib in Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) or Prolymphocytic Leukemia (PLL)

Clinical trial focusing on carfilzomib Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) or Prolymphocytic Leukemia (PLL). Study of Carfilzomib in Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) or Prolymphocytic Leukemia (PLL) .